Pnc Financial Services Group, Inc. Repligen Corp Transaction History

Pnc Financial Services Group, Inc.

$148 Billion
Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,480 shares of RGEN stock, worth $548,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,480

Previous 3,742 7.0%

Holding current value

$548,691

Previous $556,000 10.07%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 07, 2025	SELL	$123.41 - $160.92 $32,333 - $42,161	-262 Reduced 7.0%	3,480 $500,000
Q3 2024 Nov 08, 2024	SELL	$119.79 - $167.35 $60,853 - $85,013	-508 Reduced 11.95%	3,742 $556,000
Q2 2024 Aug 09, 2024	SELL	$120.0 - $182.95 $62,640 - $95,499	-522 Reduced 10.94%	4,250 $535,000
Q1 2024 May 10, 2024	BUY	$170.78 - $208.42 $35,693 - $43,559	209 Added 4.58%	4,772 $877,000
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $69,986 - $113,619	-613 Reduced 11.84%	4,563 $820,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $20,817 - $26,476	-150 Reduced 2.82%	5,176 $823,000
Q2 2023 Aug 11, 2023	SELL	$138.42 - $180.31 $138,143 - $179,949	-998 Reduced 15.78%	5,326 $753,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $617 - $792	4 Added 0.06%	6,324 $1.06 Million
Q4 2022 Feb 10, 2023	SELL	$162.42 - $220.56 $46,289 - $62,859	-285 Reduced 4.31%	6,320 $1.07 Million
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $33,527 - $53,547	-209 Reduced 3.07%	6,605 $1.24 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $153,481 - $205,129	1,091 Added 19.06%	6,814 $1.11 Million
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $53,676 - $85,900	333 Added 6.18%	5,723 $1.08 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $106,216 - $130,617	429 Added 8.65%	5,390 $1.43 Million
Q3 2021 Nov 05, 2021	SELL	$194.77 - $324.21 $346,885 - $577,418	-1,781 Reduced 26.42%	4,961 $1.43 Million
Q2 2021 Aug 06, 2021	SELL	$165.87 - $220.95 $108,644 - $144,722	-655 Reduced 8.85%	6,742 $1.35 Million
Q1 2021 May 07, 2021	BUY	$180.37 - $226.26 $40,042 - $50,229	222 Added 3.09%	7,397 $1.44 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $59,232 - $82,628	-400 Reduced 5.28%	7,175 $1.37 Million
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $52,189 - $67,423	426 Added 5.96%	7,575 $1.12 Million
Q2 2020 Aug 07, 2020	BUY	$94.33 - $140.48 $18,960 - $28,236	201 Added 2.89%	7,149 $883,000
Q1 2020 May 08, 2020	SELL	$84.96 - $109.14 $43,924 - $56,425	-517 Reduced 6.93%	6,948 $670,000
Q4 2019 Feb 07, 2020	SELL	$73.84 - $93.08 $2.31 Million - $2.91 Million	-31,316 Reduced 80.75%	7,465 $690,000
Q3 2019 Nov 08, 2019	SELL	$76.65 - $95.51 $1.24 Million - $1.54 Million	-16,157 Reduced 29.41%	38,781 $2.97 Million
Q2 2019 Aug 09, 2019	SELL	$54.2 - $85.95 $84,877 - $134,597	-1,566 Reduced 2.77%	54,938 $0
Q1 2019 May 10, 2019	SELL	$49.45 - $62.8 $2,423 - $3,077	-49 Reduced 0.09%	56,504 $0
Q4 2018 Feb 08, 2019	SELL	$48.26 - $68.88 $134,741 - $192,312	-2,792 Reduced 4.7%	56,553 $2.98 Million
Q3 2018 Nov 09, 2018	BUY	$46.8 - $58.97 $22,089 - $27,833	472 Added 0.8%	59,345 $0
Q2 2018 Aug 10, 2018	BUY	$35.26 - $47.04 $1,516 - $2,022	43 Added 0.07%	58,873 $0
Q1 2018 May 11, 2018	SELL	$30.92 - $37.27 $35,805 - $43,158	-1,158 Reduced 1.93%	58,830 $0
Q4 2017 Feb 09, 2018	SELL	$32.53 - $38.92 $11,515 - $13,777	-354 Reduced 0.59%	59,988 $0
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $2.23 Million - $2.78 Million	60,342	60,342 $0

Others Institutions Holding RGEN

# of Institutions

482

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.75B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Repligen Corp Transaction History